Mov Disord: 多基因评分,可预测帕金森发病率

2021-09-24 Freeman MedSci原创

在调整了饮食和生活方式因素后,在前瞻性的中国队列中发现了与PD发病率明显相关的PRS。

帕金森病(PD)是一种进行性神经退行性疾病,其特征是存在静止性震颤、僵硬、运动迟缓和姿势不稳。

黑质旁的多巴胺能神经元的退化是帕金森病的组织病理学标志,它先于临床症状。基因和环境因素都有助于该疾病的发生,其中高龄是最大的风险因素。

遗传学风险评估提供了在疾病发生前识别高危人群的客观定量几率。目前的方法倾向于 "共同的疾病,共同的变体common disease, common variant "假说,其中低风险等位基因占了广泛称为多基因风险评分(PRS)的遗传板的大部分。

到目前为止,PRS已被证明能更好地估计PD风险和监测疾病进展。全基因组关联研究(GWAS)使这些等位基因的鉴定成为可能;然而,GWAS在很大程度上仅限于欧洲血统的人群。由于不同血统的人群之间的遗传异质性,有必要建立一个特定种族的PRS框架。

此外,还需要考虑到可能受社会和文化差异影响的生活方式和饮食因素。为了解决目前的知识空白,新加坡南洋理工大学的 Ming-Wei Sia等人,研究了由两个亚洲特有的遗传风险变异(LRRK2 G2385R和R1628P)和四个亚洲GWAS单核苷酸多态性(SNPs)组成的PRS,并评估了其与新加坡华人健康研究(SZS)前瞻性队列的25646名研究参与者与PD发病率的关系。

他们从新加坡华人健康研究队列的25,646名参与者中前瞻性地收集遗传、饮食和生活方式信息。用亚洲特有的和顶级的全基因组关联研究变体构建PRS。用多变量Cox比例危险模型、Kaplan-Meier生存分析和一致性统计来评估PRS与PD发病率之间的关系。

在超过20年的随访期后,共发现333例发病病例。在调整了饮食和生活方式风险因素后,PRS处于最高三分位数(危险比[HR],1.81;95%置信区间[CI],1.37-2.39)和中间三分位数(HR,1.35;95%CI,1.00-1.83)的参与者患PD的风险更高,在Kaplan-Meier生存分析中,PD事件的时间更短(P < 0.001)。

这个研究的重要意义在于发现了:在调整了饮食和生活方式因素后,在前瞻性的中国队列中发现了与PD发病率明显相关的PRS。


原文出处:
Sia M, Foo J, Saffari S, et al. Polygenic Risk Scores in a Prospective Parkinson’s Disease Cohort. Mov Disord. Published online August 17, 2021:mds.28761. doi:10.1002/mds.28761

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754467, encodeId=7d901e54467a1, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Wed Oct 20 15:15:37 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013718, encodeId=d4692013e1868, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun May 01 14:15:37 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823753, encodeId=62911823e5378, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Apr 24 06:15:37 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784468, encodeId=36011e8446892, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Wed Mar 16 03:15:37 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2021-10-20 syscxl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754467, encodeId=7d901e54467a1, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Wed Oct 20 15:15:37 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013718, encodeId=d4692013e1868, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun May 01 14:15:37 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823753, encodeId=62911823e5378, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Apr 24 06:15:37 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784468, encodeId=36011e8446892, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Wed Mar 16 03:15:37 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1754467, encodeId=7d901e54467a1, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Wed Oct 20 15:15:37 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013718, encodeId=d4692013e1868, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun May 01 14:15:37 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823753, encodeId=62911823e5378, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Apr 24 06:15:37 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784468, encodeId=36011e8446892, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Wed Mar 16 03:15:37 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1754467, encodeId=7d901e54467a1, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Wed Oct 20 15:15:37 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013718, encodeId=d4692013e1868, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun May 01 14:15:37 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823753, encodeId=62911823e5378, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Apr 24 06:15:37 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784468, encodeId=36011e8446892, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Wed Mar 16 03:15:37 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-16 cmsvly

相关资讯

Mov Disord:神经丝轻链,可预测帕金森患者的认知减退

血浆NfL是PD的一个有用的预后生物标志物,可预测临床转化为轻度认知障碍或痴呆。

Mov Disord : 双相情感障碍,让帕金森“雪上加霜”

BSD作为PD的前驱症状不利于形成其病程,并与有害的神经精神特征和治疗结果有关。

Mov Disord : 绝经期越晚,帕金森患病率越低

女性绝经年龄较晚与PD的风险降低有关,

Mov Disord : 多靶点经颅电刺激,治疗冻结步态,效果如何

在轻度至中度FOG严重程度的参与者中观察到的改善值得进一步研究。在轻度至中度FOG严重程度的参与者中观察到的改善值得进一步研究。

Mov Disord: 帕金森患者的精神相关症状,血清素和多巴胺生成系统是"罪魁祸首"?

这些发现强调了血清素能变性在帕金森病不同病程后出现的几种神经精神症状的表达中的突出作用。

Mov Disord: 帕金森患者同时出现快速眼动,临床进展更快

帕金森病+pRBD患者在运动、情绪和认知症状方面进展更快

拓展阅读

Nature Medicine:重塑帕金森病治疗前景:Prasinezumab在早期帕金森病快速进展亚型中的疗效分析

文章探讨了Prasinezumab这种单克隆抗体在早期帕金森病中的潜在的治疗作用。

【帕金森病专题分享】探索帕金森病进展及诊疗全攻略

帕金森病日来临之际,我们特别推出了帕金森病专题系列文章。无论你是初入此领域的新手,还是经验丰富的专家,这里都有你需要的知识和信息。点击立即阅读,共同提升帕金森病诊疗水平!

话题:帕金森病的真相你了解多少?

我们欢迎各位老师,学者们在下方评论区共同探讨帕金森病的各个方面,包括但不限于:帕金森病的介绍、早期症状、体征、预防等都可一起分享出来。

European Radiology:弥散基础频谱成像检测早期帕金森病黑质和白质束的病理改变

为了解决弥散张量成像的局限性,研究发展了弥散基谱成像 (DBSI)以粗量化各向异性扩散张量反映轴突的完整性,其在多种中枢神经系统疾病中的敏感性和准确性已被证实。

帕金森病睡眠量表修订版(PDSS-2)

帕金森病睡眠量表修订版(PDSS-2)

神经科一周速递:热点解读进展大盘点!

一周热点分享 ,紧跟神经科学前沿,让每一次诊疗都更精准,点击立即查看!

2024 NICE 诊断指南:帕金森病远程监测设备 [DG51]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-01-25

2023 NICE 技术鉴定指南:左旋多巴/卡比多巴组合治疗伴有运动症状的晚期帕金森病[TA934]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-11-29

帕金森病患者睡眠障碍评估与护理干预的最佳证据总结

浙江中医药大学护理学院 · 2023-08-10

早中期帕金森病患者运动管理的最佳证据总结

山东第一医科大学附属省立医院老年神经内科 · 2023-05-10